KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) Polymorphisms Affect Therapeutic Efficacy of Repaglinide in Chinese Patients With Type 2 Diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) Polymorphisms Affect Therapeutic Efficacy of Repaglinide in Chinese Patients With Type 2 Diabetes

Published:2010-01-06 Issue:3 Volume:87 Page:330-335
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Yu M,Xu X-J,Yin J-Y,Wu J,Chen X,Gong Z-C,Ren H-Y,Huang Q,Sheng F-F,Zhou H-H,Liu Z-Q

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference28 articles.

1. Targeted Overactivity of β Cell KATP Channels Induces Profound Neonatal Diabetes

2. An E23K single nucleotide polymorphism in the islet ATP-sensitive potassium channel gene (Kir6.2) contributes as much to the risk of Type II diabetes in Caucasians as the PPARγ Pro12Ala variant

3. The E23K Variant of Kir6.2 Associates With Impaired Post-OGTT Serum Insulin Response and Increased Risk of Type 2 Diabetes

4. Candidate Gene Association Study in Type 2 Diabetes Indicates a Role for Genes Involved in β-Cell Function as Well as Insulin Action

5. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of KCNJ11 gene polymorphisms with the risk of type 2 diabetes mellitus: A PRISMA-driven systematic review of 30,373 individuals;2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM);2023-12-05

2. Genetics of Type 2 Diabetes;Metabolic Syndrome;2023-11-01

3. Genetics of Type 2 Diabetes;Metabolic Syndrome;2023

4. Pharmacogenomics and diabetes;Pharmacogenomics;2023

5. Risk of type 2 diabetes and KCNJ11 gene polymorphisms: a nested case–control study and meta-analysis;Scientific Reports;2022-12-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3